Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.

NCT02294253 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT02294253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02294253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence